Gov. Gavin Newsom announces California will start selling low-cost insulin in 2026

Californians will be able to buy low-cost, state-branded insulin next year, Gov. Gavin Newsom announced Thursday.

• Oct 16, 2025

California bill seeking to cap insulin co-pays at $35 heads to Newsom's desk

A bill that would cap the price of insulin in California at $35 for a 30-day supply has been approved by the state legislature and is heading to Gov. Gavin Newsom's desk.

• Sep 10, 2025

Drug middlemen illegally drive up the cost of insulin, FTC says

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

• Sep 20, 2024

California Gov. Newsom signs bill advancing universal health care, vetoes insulin price cap

On Saturday California Gov. Gavin Newsom announced the approval of Senate Bill 770, introduced by Sen. Scott Wiener (D-San Francisco). The legislation advances tangible steps toward securing universal health coverage in California. It would direct the California Health and Human Services Agency (HHS) to work with the federal government to outline the requirements of a federal waiver application.

• Oct 7, 2023

Proposed $35 price cap on insulin heads to Gov. Gavin Newsom's desk

A proposal by a Bay Area lawmaker that would cap the cost of insulin to $35 is heading to Gov. Gavin Newsom's desk after being unanimously approved by state legislators.

• Sep 13, 2023

Newsom: State will co-manufacture insulin, slashing costs

Gov. Newsom said Saturday the state of California and a generic drug manufacturer are partnering to produce affordable, state-branded insulin.

• Mar 18, 2023

Sanofi becomes latest drugmaker to announce insulin price cuts, capping cost at $35 for the privately insured

Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday. The change is effective January 1.

• Mar 17, 2023